however , when nac is given orally , in doses similar to those currently used in the treatment of chronic obstructive airways disease , its poor bioavailability , due probably to extensive first-pass metabolism , makes it unlikely that it is available to organs such as the lung for direct scavenging activity .
C0024117
chronic obstructive airways disease
C0024109
lung